APHQF - Aphria Inc.

Other OTC - Other OTC Delayed Price. Currency in USD
11.57
0.00 (0.00%)
At close: 3:59PM EDT
Stock chart is not supported by your current browser
Previous Close11.57
Open0.00
Bid0.00 x 0
Ask0.00 x 0
Day's Range0.00 - 0.00
52 Week Range
Volume0
Avg. Volume2,765,407
Market Cap2.89B
Beta (3Y Monthly)4.05
PE Ratio (TTM)85.70
EPS (TTM)0.14
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • What Analysts Think about Aphria in November
    Market Realist23 minutes ago

    What Analysts Think about Aphria in November

    Aphria (APHQF) has had one of the weakest months compared to other cannabis companies (HMMJ) such as Canopy Growth (WEED), Supreme Cannabis (SPRWF), and HEXO (HEXO). In this month alone, the stock has declined by nearly 21.4%. Let’s look at what analysts think.

  • What Analysts Recommend for Cronos Group in November
    Market Realistyesterday

    What Analysts Recommend for Cronos Group in November

    On November 13, Cronos Group (CRON) reported its quarterly results. It posted sales of 3.7 million Canadian dollars, which beat analysts’ consensus estimate of 3.6 million Canadian dollars, and the margins also remained healthy. However, the company’s bottom line struggled. Read more at Key Updates on Cronos Group’s Third-Quarter Earnings. Let’s look at what analysts recommend for the stock.

  • November Update: How Analysts Rate Cannabis Stocks after Earnings
    Market Realistyesterday

    November Update: How Analysts Rate Cannabis Stocks after Earnings

    While the overall markets were filled with negative sentiments, the earnings season for cannabis stocks dampened the excitement in the sector. Most of the cannabis companies missed consensus estimates. In the above chart, you can see some of the big cannabis names (HMMJ) that saw an impressive run-up in October 2018 as marijuana became legal in Canada.

  • Key Takeaways from Canopy Growth’s Second-Quarter Earnings
    Market Realist6 days ago

    Key Takeaways from Canopy Growth’s Second-Quarter Earnings

    On November 14, Canopy Growth (WEED) (CGC) reported its second-quarter earnings, which largely disappointed the market. As a result, the stock took a beating with an 11% decline to $34.3. The company reported revenues of 23.3 million Canadian dollars, which missed analysts’ estimate of 61.7 million Canadian dollars.

  • Does Aurora Think Recreational Cannabis Sales Lived Up to Hype?
    Market Realist8 days ago

    Does Aurora Think Recreational Cannabis Sales Lived Up to Hype?

    One of the most anticipated aspects of Aurora Cannabis’s (ACB) (ACBFF) earnings results was an update on the recreational cannabis (HMMJ) market demand. In its press release, Aurora Cannabis stated that the company had a “strong performance” in the recreational cannabis segment during the quarter, which ended in September 2018. During the first quarter, the company stated that its brands accounted for nearly 30% of the total cannabis supplied through the OCS (Ontario Cannabis Store) with San Rafael being Aurora’s top brand sold in Ontario.

  • Most Cannabis Companies Expected to Report Losses for the Quarter
    Market Realist8 days ago

    Most Cannabis Companies Expected to Report Losses for the Quarter

    Aurora Cannabis (ACB) is estimated to report a loss per share of 0.07 Canadian dollars, which would be lower than the profit per share of 0.01 Canadian dollars in the corresponding quarter of 2017. Cronos (CRON) is expected to report a loss per share of 0.02 Canadian dollars, which is flat compared to the corresponding quarter a year ago. Tilray (TLRY) is expected to report a loss per share of 0.13 Canadian dollars for the quarter.

  • Cannabis Companies’ Income from Core Operations to Be Negative
    Market Realist8 days ago

    Cannabis Companies’ Income from Core Operations to Be Negative

    As we discussed earlier in this series, cannabis companies (MJ) are expected to report impressive sales growth and healthy margins. However, it’s important to see how these figures could impact cash flows and earnings.

  • Why Canopy Growth Partnered with The Brink’s Company
    Market Realist12 days ago

    Why Canopy Growth Partnered with The Brink’s Company

    On November 8, Canopy Growth (CGC) (WEED) announced a multiyear partnership with an established logistics and cash management provider—The Brink’s Company (BCO). The Brink’s Company will be used in Canada and global markets where Canopy Growth has operations. Three markets—Brazil, France, and Mexico—show that most of the transactions take place in cash.

  • Jeff Sessions’ Resignation Could Be Good News for Cannabis Stocks
    Market Realist13 days ago

    Jeff Sessions’ Resignation Could Be Good News for Cannabis Stocks

    On November 7, US Attorney General Jeff Sessions resigned from his position. The Justice Department’s chief of staff, Matt Whitaker, will serve as the acting attorney general. This development could bring some optimism to the cannabis sector in the US, as Jeff Sessions was one of the harshest critics of marijuana.

  • Newsfile16 days ago

    Rapid Dose Therapeutics Signs an Exclusive Preferred Global Vendor Agreement with Aphria

    Toronto, Burlington, Ontario--(Newsfile Corp. - November 5, 2018) - ACME Resources Corp. ("ACME") and Rapid Dose Therapeutics Inc. ("RDT") are pleased to announce that RDT and Aphria Inc. ("Aphria") (TSX: APHA) (NYSE: APHA) have signed a definitive agreement granting Aphria exclusive preferred global vendor status for the production and sales of RDT's QuickStrip™ technology for both medicinal and adult-use cannabis markets around the world. RDT's game-changing, proprietary QuickStrip™ technology is a Quick, ...

  • Aphria's Australian-Based Partner Althea Granted Manufacture Licence
    CNW Group19 days ago

    Aphria's Australian-Based Partner Althea Granted Manufacture Licence

    LEAMINGTON, ON, Nov. 1, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APHA and NYSE: APHA) today announced that its Australian-based partner Althea Company Pty Ltd. ("Althea" or the "Australian Company") has been granted a Manufacture Licence by the Australian Government's Office of Drug Control. The license provides Althea with authorization to manufacture extracts and tinctures of cannabis and cannabis resin in accordance with relevant manufacture permits. "We are excited to see our Australian partner achieve yet another milestone in receiving its Manufacture License.

  • ACCESSWIRE20 days ago

    Cannabis and Biotech Stocks That Could Bounce

    HENDERSON, NV / ACCESSWIRE / November 1, 2018 / A stem cell play we like a lot is BioRestorative Therapies, Inc.,(BRTX) a life sciences company focused on stem cell-based therapies. Defined Health is a business development and strategy consulting firm that has worked with many of the leading companies in the pharmaceutical, biotech and healthcare industries for over 25 years. BRTX plans to use the results of the review to further refine its planned activities around BRTX-100, including potential licensing, co-development and commercialization activities.

  • ACCESSWIRE22 days ago

    3 Marijuana Stocks Looking Toward A Market Turnaround

    Leading up to the October 17th "legalization date" in Canada, investors saw a surge in cannabis stock interest. Canadian producers and retailers have been unable to keep up with the demand among consumers for cannabis products. With this in mind, we look at 3 marijuana stocks to watch as legalization continues to reach across North America.

  • ACCESSWIRE22 days ago

    Cannabis and Tech Firms Setting Up For Big Runs

    HENDERSON, NV / ACCESSWIRE / October 30, 2018 / After a rough week last week for many investors we searched for stocks set up to run this week and help them make up some losses. One company we have discovered ...

  • Aphria to commence trading on the NYSE on November 2
    CNW Group22 days ago

    Aphria to commence trading on the NYSE on November 2

    LEAMINGTON, ON, Oct. 30, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH) and (US OTC: APHQF) announced today that its common shares have been approved for listing on the New York Stock Exchange ("NYSE") and will commence trading effective the open of markets on November 2, 2018.

  • ACCESSWIRE23 days ago

    Today's Research Reports on Trending Tickers: Canopy Growth and Aphria

    NEW YORK, NY / ACCESSWIRE / October 29, 2018 / U.S. equities rolled back on Friday as disappointing corporate earnings added to the bearish sentiment in the market. The Dow Jones Industrial Average shed ...

  • Marijuana Stock Earnings Reports: 3 Things to Expect This Quarter
    Motley Fool25 days ago

    Marijuana Stock Earnings Reports: 3 Things to Expect This Quarter

    Will pot stocks deliver the green?

  • ACCESSWIRE26 days ago

    Market is Bouncing and This Company is Set to Do the Same

    HENDERSON, NV / ACCESSWIRE / October 26, 2018 / After pouring over several companies, we've found a few that look set for a major bounce in conjunction with the market. One company we like a lot that is prime for a rebound is BioRestorative Therapies, Inc. (BRTX) a life sciences company focused on stem cell-based therapies. BRTX looks like it has found that support and is on the brink of its next run.

  • Aphria Introduces Dr. Jonathan Simone, PhD as Director of Research and Clinical Studies
    CNW Group27 days ago

    Aphria Introduces Dr. Jonathan Simone, PhD as Director of Research and Clinical Studies

    LEAMINGTON, ON, Oct. 25, 2018 /CNW/ - Aphria Inc. ("Aphria" or the "Company") (TSX: APH and US OTC: APHQF) today officially introduced Dr. Jonathan Simone, PhD as the Company's Director of Research and Clinical Studies. Dr. Simone joined Aphria in July 2018 and serves as the primary liaison between the Company's science, technical and medical division teams and outside medical, academic and clinical centers.

  • ACCESSWIRE27 days ago

    3 Marijuana Stocks Heading Higher After Breaking News

    CORAL GABLES, FL / ACCESSWIRE / October 25, 2018 / According to a new report by Grand View Research, Inc., the global legal marijuana market is expected to reach $146.4 billion by end of 2025. This week the market along with several cannabis stocks are looking to turn a corner and head back toward previous highs. Integrated Cannabis Company (ICNAF) (ICAN.CN) reported today that the marijuana company has agreed to license Cannabidiol-formulated gummies.

  • Here's Why 2019's Top Marijuana Stocks Will Be Different
    Motley Fool27 days ago

    Here's Why 2019's Top Marijuana Stocks Will Be Different

    Expect a shuffling in next year's top-performing pot stocks.

  • Analyzing the Cannabis Sector’s EV-to-EBITDA Multiple
    Market Realist27 days ago

    Analyzing the Cannabis Sector’s EV-to-EBITDA Multiple

    In this part of the series, we’ll discuss the forward EV-to-EBITDA median multiple of nine cannabis stocks as of October 23.

  • GlobeNewswire27 days ago

    Solar Energy and its future in the Cannabis Market; Aurora Cannabis, Solar Integrated Roofing Corporation (OTC: SIRC), Canadian Solar Inc., Aphria Inc.

    Investorideas.com, a global news source covering leading sectors including both cannabis and solar stocks, issues a snapshot looking at how solar energy has and will play a key role in the future of the cannabis sector. Companies mentioned: Aurora Cannabis Inc. (TSX: ACB.TO) (NYSE: ACB), Solar Integrated Roofing Corporation (OTC: SIRC), Canadian Solar Inc. (NASDAQ: CSIQ), Aphria Inc. (TSX: APH.TO), (OTC: APHQF), and Emerald Health Therapeutics, Inc.

  • ACCESSWIRE28 days ago

    Medical Cannabis, and Biotech Stocks That Are Set to Explode

    HENDERSON, NV / ACCESSWIRE / October 24, 2018 / The cannabis industry took a bit of a hit yesterday, making for several bounce opportunities we've highlighted below. A fascinating biotech firm we discovered ...

  • ACCESSWIRE29 days ago

    CBD Company Announces Amazing Results

    HENDERSON, NV / ACCESSWIRE / October 23, 2018 / Last week, one of our favorite CBD companies released some fantastic news. Chineseinvestors.com Inc. (CIIX) announced their Financial Highlights for their ...